MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
F-Star and Merck Serono to Collaborate in the Discovery and Development of Novel Targeted Biologics.
Guest UserSeptember 7, 2011
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

GenKyoTex Starts Phase 1 Trial with First in Class NOX inhibitor GKT137831. Dual NOX1/4 Inhibitor Targets Treatment of Diabetic Nephropathy.

Guest UserOctober 31, 2011
Next

FierceBiotech Names F-star a 2011 Fierce 15 Company.

Guest UserSeptember 6, 2011

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact